Aurelia Bruneau

Aurelia Bruneau

Auto-generated profile, based on publicly available information

Aurelia Bruneau

INRAE, Micalis Institute, UMR 1319, Paris‐Saclay University, AgroParisTech Jouy‐en‐Josas France

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 December 2024 in Allergy
Verified
Journal Article
Open access
ALAnais LEMOINE
Anais LEMOINE
NKNathalie Kapel
Nathalie Kapel
INIoannis Nicolis
Ioannis Nicolis
PTP. Tounian
P. Tounian
ABA. Bruneau
A. Bruneau
MTMuriel Thomas
Muriel Thomas
Background: Food protein‐induced enterocolitis syndrome (FPIES) is a non‐IgE‐mediated allergy without known biomarkers. We aimed to compare fecal biomarkers related to gut inflammation and immunity in children with FPIES, with resolved FPIES (tolerant), and in matched controls.Methods: Stools were collected from FPIES children on elimination diet, before and after an oral food challenge (OFC) performed to assess their natural tolerance, at the end of a follow‐up in tolerant FPIES children, and in matched controls (1:1 ratio). Concentrations of calprotectin, EDN (eosinophilic derived neurotoxin), and secretory IgA (sIgA) underwent comparative paired analysis.Results: Thirty‐eight patients were included (age: 1.3 years old, interquartile range: IQR [0.9–2.0]), of which 22 became tolerant during follow‐up. Upon inclusion, allergic patients and controls had similar concentrations of calprotectin (38 μg/g [8–85] vs. 27 μg/g [11–46], p = 0.15) and EDN (504 ng/g [275–1252] vs. 516 ng/g [215–844], p = 0.86). However, concentrations of these inflammatory biomarkers increased transiently after a failed OFC (p < 0.001 and p = 0.01 respectively), without correlating with the severity of an allergic reaction. sIgA were higher in allergic than in tolerant patients: 2224 μg/g [878–3529] vs. 794 μg/g [699–1767] (p < 0.01). Calprotectin, EDN, and sIgA were comparable in tolerant patients and controls. sIgA less than 2637 μg/g had a negative predictive value of 75.3% for the differentiation allergic patients from tolerant patients and controls (area under curve: 0.63, 95% CI: 0.52–0.74).Conclusion: A few days after an acute allergic reaction, there was no detectable chronic gut inflammation in FPIES. sIgA may be a useful tool for clinicians in timing OFC.

7 December 2025 in Data in Brief
Verified
Journal Article
Open access
MBMélanie Briard
Mélanie Briard
BGBlanche Guillon
Blanche Guillon
EVEric Venot
Eric Venot
MGMarta Grauso
Marta Grauso
ABAurélia Bruneau
Aurélia Bruneau
VSVinciane Saint-Criq
Vinciane Saint-Criq
Severe asthma (SA) is a heterogeneous condition characterized by multiple phenotypes, each characterized by different endotypes. Understanding the mechanisms occurring in the lungs of children with SA can help in understanding pathogenesis and in providing the most effective therapeutic strategies. This article describes microbiota, metabolites, and soluble immune components assessed in bronchoalveolar lavage (BAL) fluids from children with severe asthma (n = 20) and age-matched disease controls (n = 10). The article includes: (i) the protocol used to process BAL samples for 16S rRNA gene amplicon sequencing, metabolomic profiling and immune components assays; (ii) the bioinformatics steps applied to 16S rRNA and metabolomics dataset; (iii) an overview of the raw 16S rRNA gene amplicon sequencing data, presented as ASV and affiliation tables, raw data from untargeted metabolomics and the abundances of each of the eighty eight metabolites annotated with the highest confidence level, and concentrations of seventy three cytokines and of total IgG, IgA and IgE. Each dataset is available in the INRAE data repository (https://entrepot.recherche.data.gouv.fr/dataverse/inrae) with respective DOI: MICROBIOTA: 10.57745/LL3TFW, METABOLITES: 10.57745/1L8VRI, IMMUNE COMPONENTS: 10.57745/JOOGRQ

28 April 2026 in Allergy
Verified
Journal Article
Open access
ALAnais LEMOINE
Anais LEMOINE
KAKarine Adel-Patient
Karine Adel-Patient
NKNathalie Kapel
Nathalie Kapel
CMCamille Mayeur
Camille Mayeur
MRMarie‐Noelle Rossignol
Marie‐Noelle Rossignol
INIoannis Nicolis
Ioannis Nicolis
Background: Gut microbiota and their metabolites play a key role in digestive dysimmunity and tolerance breakdown, leading to pathologies such as food protein‐induced enterocolitis syndrome (FPIES). This study aimed to compare both the gut and salivary microbiota over time between the allergic and tolerant patients and the matched controls. Methods: Faecal and salivary samples were collected longitudinally from FPIES allergic patients on an elimination diet, and after their natural tolerance acquisition, and from matched controls (1:1 ratio). 16S rRNA gene sequencing and biostatistical analyses (ALDEx2, ANCOM‐BC, DESeq2, LEfSe, and MaAsLIN2) were used to compare microbiota composition between groups. The measurement of faecal short‐chain fatty acids (SCFAs) using gas chromatography evaluated the gut microbiota functions. Results: Thirty‐eight allergic patients were included (median age: 1.3 years), and 22 became tolerant over time. Allergic patients exhibited lower gut and salivary alpha‐diversities, and several different genera (12 in stools, including less Ruminococcus , and 2 in saliva), and higher relative abundance of acetate than the controls. With tolerance acquisition, faecal alpha‐diversities partially increased, whereas SCFAs normalised. Ultimately, there were more differences in faecal and salivary microbiota in allergic patients versus after tolerance acquisition (i.e., more Blautia , Ruminococcus , Faecalibacterium , Prevotella ‐9, and less Escherichia – Shigella in tolerant patients) than between the controls over time. Conclusion: The faecal and salivary dysbiosis observed in allergic patients with FPIES partially resolved after tolerance acquisition. Understanding the underlying mechanisms of dysbiosis is crucial to prevent and help manage FPIES. A prolonged follow‐up could determine whether dysbiosis resolution may be complete, and whether this early infancy dysbiosis has long‐term consequences on health.